— Know what they know.
Not Investment Advice

SCYX NASDAQ

SCYNEXIS, Inc.
1W: +16.6% 1M: -1.9% 3M: +8.2% YTD: +701.9% 1Y: +533.4% 3Y: +142.7% 5Y: -8.2%
$5.12
-0.25 (-4.66%)
 
Weekly Expected Move ±11.7%
$4 $5 $5 $6 $6
NASDAQ · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 53 · $32.2M mcap · 6M float · 3.97% daily turnover · Short 54% of daily vol

Cash Flow Trends

Operating Cash Flow
-$5M +78.0% ▲
Capital Expenditures
$0 +0.0% ▲
Free Cash Flow
-$5M +78.0% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$5M +127.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$33M-$63M$67M-$21M-$9M
Depreciation & Amort.$379K$606K$580K$2M$312K
Stock-Based Comp.$2M$4M$3M$3M$3M
Change in Working Capital$3M$764K-$31M$7M$6M
Other Non-Cash Items-$27M-$22M$21M-$15M-$6M
Operating Cash Flow-$55M-$80M$60M-$24M-$5M
— Investing Activities —
Capital Expenditures-$1M-$9K$0$0$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0-$27M-$85M-$36M-$19M
Investment Sales$0$0$51M$43M$43M
Other Investing$0$0$0$0$0
Investing Cash Flow-$1M-$27M-$35M$6M$24M
— Financing Activities —
Net Debt Issuance$30M$5M-$37M$0-$14M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$1M-$26K-$93K$0$0
Financing Cash Flow$67M$49M-$37M-$139K-$14M
Net Change in Cash$11M-$59M-$11M-$18M$5M
Cash End of Period$105M$46M$35M$17M$21M
Free Cash Flow-$56M-$80M$60M-$24M-$5M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms